nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A5—Niacin—atherosclerosis	0.15	0.224	CbGbCtD
Clonidine—CYP3A5—Rosuvastatin—atherosclerosis	0.0496	0.0743	CbGbCtD
Clonidine—CYP3A5—Simvastatin—atherosclerosis	0.0461	0.069	CbGbCtD
Clonidine—CYP3A5—Pravastatin—atherosclerosis	0.0451	0.0676	CbGbCtD
Clonidine—CYP3A5—Lovastatin—atherosclerosis	0.0451	0.0676	CbGbCtD
Clonidine—CYP2D6—Niacin—atherosclerosis	0.0358	0.0536	CbGbCtD
Clonidine—ABCB1—Ezetimibe—atherosclerosis	0.0323	0.0483	CbGbCtD
Clonidine—ABCB1—Simvastatin—atherosclerosis	0.03	0.0449	CbGbCtD
Clonidine—ABCB1—Lovastatin—atherosclerosis	0.0294	0.044	CbGbCtD
Clonidine—ABCB1—Pravastatin—atherosclerosis	0.0294	0.044	CbGbCtD
Clonidine—CYP2D6—Simvastatin—atherosclerosis	0.0283	0.0423	CbGbCtD
Clonidine—CYP2D6—Lovastatin—atherosclerosis	0.0277	0.0414	CbGbCtD
Clonidine—CYP2D6—Pravastatin—atherosclerosis	0.0277	0.0414	CbGbCtD
Clonidine—CYP3A4—Rosuvastatin—atherosclerosis	0.0194	0.029	CbGbCtD
Clonidine—CYP3A4—Ezetimibe—atherosclerosis	0.0194	0.029	CbGbCtD
Clonidine—CYP3A4—Simvastatin—atherosclerosis	0.018	0.0269	CbGbCtD
Clonidine—CYP3A4—Pravastatin—atherosclerosis	0.0176	0.0263	CbGbCtD
Clonidine—CYP3A4—Lovastatin—atherosclerosis	0.0176	0.0263	CbGbCtD
Clonidine—Diclofenac—PLA2G2A—atherosclerosis	0.00346	0.55	CrCbGaD
Clonidine—Diclofenac—ALOX5—atherosclerosis	0.00124	0.197	CrCbGaD
Clonidine—Diclofenac—CXCL8—atherosclerosis	0.00103	0.163	CrCbGaD
Clonidine—Urinary tract infection—Pravastatin—atherosclerosis	0.000681	0.00352	CcSEcCtD
Clonidine—Cough—Rosuvastatin—atherosclerosis	0.000667	0.00345	CcSEcCtD
Clonidine—Angiopathy—Ezetimibe—atherosclerosis	0.000662	0.00342	CcSEcCtD
Clonidine—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000658	0.0034	CcSEcCtD
Clonidine—Alopecia—Lovastatin—atherosclerosis	0.000657	0.0034	CcSEcCtD
Clonidine—Arthralgia—Rosuvastatin—atherosclerosis	0.000651	0.00337	CcSEcCtD
Clonidine—Alopecia—Ezetimibe—atherosclerosis	0.000645	0.00334	CcSEcCtD
Clonidine—Rhinitis—Niacin—atherosclerosis	0.000641	0.00331	CcSEcCtD
Clonidine—Mental disorder—Ezetimibe—atherosclerosis	0.000639	0.00331	CcSEcCtD
Clonidine—Hepatitis—Niacin—atherosclerosis	0.000639	0.00331	CcSEcCtD
Clonidine—Hypoaesthesia—Niacin—atherosclerosis	0.000636	0.00329	CcSEcCtD
Clonidine—Erythema—Ezetimibe—atherosclerosis	0.000635	0.00329	CcSEcCtD
Clonidine—Rhinitis—Pravastatin—atherosclerosis	0.000631	0.00326	CcSEcCtD
Clonidine—Hepatitis—Pravastatin—atherosclerosis	0.000629	0.00325	CcSEcCtD
Clonidine—Confusional state—Rosuvastatin—atherosclerosis	0.000629	0.00325	CcSEcCtD
Clonidine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000626	0.00324	CcSEcCtD
Clonidine—Muscle spasms—Lovastatin—atherosclerosis	0.000623	0.00322	CcSEcCtD
Clonidine—Infection—Rosuvastatin—atherosclerosis	0.00062	0.00321	CcSEcCtD
Clonidine—Alopecia—Simvastatin—atherosclerosis	0.000615	0.00318	CcSEcCtD
Clonidine—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000612	0.00316	CcSEcCtD
Clonidine—Muscle spasms—Ezetimibe—atherosclerosis	0.000611	0.00316	CcSEcCtD
Clonidine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000611	0.00316	CcSEcCtD
Clonidine—Vision blurred—Lovastatin—atherosclerosis	0.00061	0.00316	CcSEcCtD
Clonidine—Mental disorder—Simvastatin—atherosclerosis	0.00061	0.00315	CcSEcCtD
Clonidine—Tremor—Lovastatin—atherosclerosis	0.000607	0.00314	CcSEcCtD
Clonidine—Erythema—Simvastatin—atherosclerosis	0.000606	0.00313	CcSEcCtD
Clonidine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000601	0.00311	CcSEcCtD
Clonidine—Eye disorder—Niacin—atherosclerosis	0.000597	0.00309	CcSEcCtD
Clonidine—Tinnitus—Niacin—atherosclerosis	0.000596	0.00308	CcSEcCtD
Clonidine—Angioedema—Lovastatin—atherosclerosis	0.000592	0.00306	CcSEcCtD
Clonidine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000589	0.00305	CcSEcCtD
Clonidine—Tinnitus—Pravastatin—atherosclerosis	0.000587	0.00303	CcSEcCtD
Clonidine—Malaise—Lovastatin—atherosclerosis	0.000584	0.00302	CcSEcCtD
Clonidine—Cardiac disorder—Pravastatin—atherosclerosis	0.000584	0.00302	CcSEcCtD
Clonidine—Muscle spasms—Simvastatin—atherosclerosis	0.000582	0.00301	CcSEcCtD
Clonidine—Angioedema—Ezetimibe—atherosclerosis	0.00058	0.003	CcSEcCtD
Clonidine—Angiopathy—Niacin—atherosclerosis	0.00058	0.003	CcSEcCtD
Clonidine—Malaise—Ezetimibe—atherosclerosis	0.000573	0.00296	CcSEcCtD
Clonidine—Vision blurred—Simvastatin—atherosclerosis	0.000571	0.00295	CcSEcCtD
Clonidine—Arrhythmia—Niacin—atherosclerosis	0.000571	0.00295	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000568	0.00294	CcSEcCtD
Clonidine—Tremor—Simvastatin—atherosclerosis	0.000568	0.00294	CcSEcCtD
Clonidine—Alopecia—Niacin—atherosclerosis	0.000565	0.00292	CcSEcCtD
Clonidine—Insomnia—Rosuvastatin—atherosclerosis	0.000564	0.00292	CcSEcCtD
Clonidine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000562	0.00291	CcSEcCtD
Clonidine—Arrhythmia—Pravastatin—atherosclerosis	0.000562	0.00291	CcSEcCtD
Clonidine—Palpitations—Ezetimibe—atherosclerosis	0.000561	0.0029	CcSEcCtD
Clonidine—Paraesthesia—Rosuvastatin—atherosclerosis	0.00056	0.0029	CcSEcCtD
Clonidine—Erythema—Niacin—atherosclerosis	0.000556	0.00288	CcSEcCtD
Clonidine—Alopecia—Pravastatin—atherosclerosis	0.000556	0.00288	CcSEcCtD
Clonidine—Cough—Ezetimibe—atherosclerosis	0.000554	0.00287	CcSEcCtD
Clonidine—Angioedema—Simvastatin—atherosclerosis	0.000553	0.00286	CcSEcCtD
Clonidine—Chest pain—Lovastatin—atherosclerosis	0.000551	0.00285	CcSEcCtD
Clonidine—Arthralgia—Lovastatin—atherosclerosis	0.000551	0.00285	CcSEcCtD
Clonidine—Anxiety—Lovastatin—atherosclerosis	0.000549	0.00284	CcSEcCtD
Clonidine—Malaise—Simvastatin—atherosclerosis	0.000546	0.00283	CcSEcCtD
Clonidine—Tension—Niacin—atherosclerosis	0.000546	0.00282	CcSEcCtD
Clonidine—Discomfort—Lovastatin—atherosclerosis	0.000545	0.00282	CcSEcCtD
Clonidine—Chest pain—Ezetimibe—atherosclerosis	0.000541	0.0028	CcSEcCtD
Clonidine—Arthralgia—Ezetimibe—atherosclerosis	0.000541	0.0028	CcSEcCtD
Clonidine—Nervousness—Niacin—atherosclerosis	0.00054	0.00279	CcSEcCtD
Clonidine—Dry mouth—Lovastatin—atherosclerosis	0.000539	0.00279	CcSEcCtD
Clonidine—Tension—Pravastatin—atherosclerosis	0.000537	0.00278	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000537	0.00278	CcSEcCtD
Clonidine—Muscle spasms—Niacin—atherosclerosis	0.000535	0.00277	CcSEcCtD
Clonidine—Discomfort—Ezetimibe—atherosclerosis	0.000534	0.00276	CcSEcCtD
Clonidine—Pain—Rosuvastatin—atherosclerosis	0.000533	0.00276	CcSEcCtD
Clonidine—Constipation—Rosuvastatin—atherosclerosis	0.000533	0.00276	CcSEcCtD
Clonidine—Confusional state—Lovastatin—atherosclerosis	0.000533	0.00276	CcSEcCtD
Clonidine—Nervousness—Pravastatin—atherosclerosis	0.000532	0.00275	CcSEcCtD
Clonidine—Dry mouth—Ezetimibe—atherosclerosis	0.000529	0.00274	CcSEcCtD
Clonidine—Muscle spasms—Pravastatin—atherosclerosis	0.000526	0.00272	CcSEcCtD
Clonidine—Infection—Lovastatin—atherosclerosis	0.000525	0.00272	CcSEcCtD
Clonidine—Vision blurred—Niacin—atherosclerosis	0.000524	0.00271	CcSEcCtD
Clonidine—Confusional state—Ezetimibe—atherosclerosis	0.000523	0.0027	CcSEcCtD
Clonidine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000517	0.00268	CcSEcCtD
Clonidine—Vision blurred—Pravastatin—atherosclerosis	0.000516	0.00267	CcSEcCtD
Clonidine—Arthralgia—Simvastatin—atherosclerosis	0.000516	0.00267	CcSEcCtD
Clonidine—Chest pain—Simvastatin—atherosclerosis	0.000516	0.00267	CcSEcCtD
Clonidine—Infection—Ezetimibe—atherosclerosis	0.000515	0.00266	CcSEcCtD
Clonidine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000514	0.00266	CcSEcCtD
Clonidine—Anxiety—Simvastatin—atherosclerosis	0.000514	0.00266	CcSEcCtD
Clonidine—Tremor—Pravastatin—atherosclerosis	0.000513	0.00265	CcSEcCtD
Clonidine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00051	0.00264	CcSEcCtD
Clonidine—Discomfort—Simvastatin—atherosclerosis	0.00051	0.00264	CcSEcCtD
Clonidine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000508	0.00263	CcSEcCtD
Clonidine—Angioedema—Niacin—atherosclerosis	0.000508	0.00263	CcSEcCtD
Clonidine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000508	0.00263	CcSEcCtD
Clonidine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000508	0.00263	CcSEcCtD
Clonidine—Anorexia—Lovastatin—atherosclerosis	0.000504	0.00261	CcSEcCtD
Clonidine—Skin disorder—Ezetimibe—atherosclerosis	0.000504	0.0026	CcSEcCtD
Clonidine—Angioedema—Pravastatin—atherosclerosis	0.0005	0.00259	CcSEcCtD
Clonidine—Syncope—Niacin—atherosclerosis	0.000499	0.00258	CcSEcCtD
Clonidine—Confusional state—Simvastatin—atherosclerosis	0.000498	0.00258	CcSEcCtD
Clonidine—Urticaria—Rosuvastatin—atherosclerosis	0.000495	0.00256	CcSEcCtD
Clonidine—Oedema—Simvastatin—atherosclerosis	0.000494	0.00256	CcSEcCtD
Clonidine—Malaise—Pravastatin—atherosclerosis	0.000494	0.00255	CcSEcCtD
Clonidine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000493	0.00255	CcSEcCtD
Clonidine—Palpitations—Niacin—atherosclerosis	0.000492	0.00254	CcSEcCtD
Clonidine—Infection—Simvastatin—atherosclerosis	0.000491	0.00254	CcSEcCtD
Clonidine—Loss of consciousness—Niacin—atherosclerosis	0.000489	0.00253	CcSEcCtD
Clonidine—Cough—Niacin—atherosclerosis	0.000485	0.00251	CcSEcCtD
Clonidine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000484	0.0025	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000482	0.00249	CcSEcCtD
Clonidine—Insomnia—Lovastatin—atherosclerosis	0.000478	0.00247	CcSEcCtD
Clonidine—Cough—Pravastatin—atherosclerosis	0.000478	0.00247	CcSEcCtD
Clonidine—Paraesthesia—Lovastatin—atherosclerosis	0.000475	0.00245	CcSEcCtD
Clonidine—Arthralgia—Niacin—atherosclerosis	0.000474	0.00245	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000472	0.00244	CcSEcCtD
Clonidine—Anorexia—Simvastatin—atherosclerosis	0.000471	0.00244	CcSEcCtD
Clonidine—Dyspnoea—Lovastatin—atherosclerosis	0.000471	0.00244	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00047	0.00243	CcSEcCtD
Clonidine—Insomnia—Ezetimibe—atherosclerosis	0.000469	0.00243	CcSEcCtD
Clonidine—Chest pain—Pravastatin—atherosclerosis	0.000466	0.00241	CcSEcCtD
Clonidine—Arthralgia—Pravastatin—atherosclerosis	0.000466	0.00241	CcSEcCtD
Clonidine—Paraesthesia—Ezetimibe—atherosclerosis	0.000465	0.00241	CcSEcCtD
Clonidine—Anxiety—Pravastatin—atherosclerosis	0.000465	0.0024	CcSEcCtD
Clonidine—Dry mouth—Niacin—atherosclerosis	0.000463	0.0024	CcSEcCtD
Clonidine—Dyspnoea—Ezetimibe—atherosclerosis	0.000462	0.00239	CcSEcCtD
Clonidine—Discomfort—Pravastatin—atherosclerosis	0.000461	0.00238	CcSEcCtD
Clonidine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000459	0.00238	CcSEcCtD
Clonidine—Decreased appetite—Lovastatin—atherosclerosis	0.000459	0.00238	CcSEcCtD
Clonidine—Fatigue—Lovastatin—atherosclerosis	0.000456	0.00236	CcSEcCtD
Clonidine—Oedema—Niacin—atherosclerosis	0.000454	0.00235	CcSEcCtD
Clonidine—Pain—Lovastatin—atherosclerosis	0.000452	0.00234	CcSEcCtD
Clonidine—Constipation—Lovastatin—atherosclerosis	0.000452	0.00234	CcSEcCtD
Clonidine—Confusional state—Pravastatin—atherosclerosis	0.000451	0.00233	CcSEcCtD
Clonidine—Decreased appetite—Ezetimibe—atherosclerosis	0.000451	0.00233	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00045	0.00233	CcSEcCtD
Clonidine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000448	0.00232	CcSEcCtD
Clonidine—Asthenia—Rosuvastatin—atherosclerosis	0.000447	0.00231	CcSEcCtD
Clonidine—Insomnia—Simvastatin—atherosclerosis	0.000447	0.00231	CcSEcCtD
Clonidine—Oedema—Pravastatin—atherosclerosis	0.000447	0.00231	CcSEcCtD
Clonidine—Fatigue—Ezetimibe—atherosclerosis	0.000447	0.00231	CcSEcCtD
Clonidine—Shock—Niacin—atherosclerosis	0.000447	0.00231	CcSEcCtD
Clonidine—Infection—Pravastatin—atherosclerosis	0.000444	0.0023	CcSEcCtD
Clonidine—Paraesthesia—Simvastatin—atherosclerosis	0.000444	0.0023	CcSEcCtD
Clonidine—Pain—Ezetimibe—atherosclerosis	0.000443	0.00229	CcSEcCtD
Clonidine—Constipation—Ezetimibe—atherosclerosis	0.000443	0.00229	CcSEcCtD
Clonidine—Tachycardia—Niacin—atherosclerosis	0.000443	0.00229	CcSEcCtD
Clonidine—Pruritus—Rosuvastatin—atherosclerosis	0.000441	0.00228	CcSEcCtD
Clonidine—Skin disorder—Niacin—atherosclerosis	0.000441	0.00228	CcSEcCtD
Clonidine—Dyspnoea—Simvastatin—atherosclerosis	0.000441	0.00228	CcSEcCtD
Clonidine—Hyperhidrosis—Niacin—atherosclerosis	0.000439	0.00227	CcSEcCtD
Clonidine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000438	0.00226	CcSEcCtD
Clonidine—Feeling abnormal—Lovastatin—atherosclerosis	0.000436	0.00225	CcSEcCtD
Clonidine—Anorexia—Niacin—atherosclerosis	0.000433	0.00224	CcSEcCtD
Clonidine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000432	0.00224	CcSEcCtD
Clonidine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000432	0.00224	CcSEcCtD
Clonidine—Decreased appetite—Simvastatin—atherosclerosis	0.00043	0.00222	CcSEcCtD
Clonidine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000427	0.00221	CcSEcCtD
Clonidine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000427	0.00221	CcSEcCtD
Clonidine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000427	0.00221	CcSEcCtD
Clonidine—Fatigue—Simvastatin—atherosclerosis	0.000426	0.0022	CcSEcCtD
Clonidine—Anorexia—Pravastatin—atherosclerosis	0.000426	0.0022	CcSEcCtD
Clonidine—Hypotension—Niacin—atherosclerosis	0.000424	0.00219	CcSEcCtD
Clonidine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000424	0.00219	CcSEcCtD
Clonidine—Constipation—Simvastatin—atherosclerosis	0.000423	0.00219	CcSEcCtD
Clonidine—Pain—Simvastatin—atherosclerosis	0.000423	0.00219	CcSEcCtD
Clonidine—Urticaria—Lovastatin—atherosclerosis	0.00042	0.00217	CcSEcCtD
Clonidine—Abdominal pain—Lovastatin—atherosclerosis	0.000418	0.00216	CcSEcCtD
Clonidine—Body temperature increased—Lovastatin—atherosclerosis	0.000418	0.00216	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000414	0.00214	CcSEcCtD
Clonidine—Dizziness—Rosuvastatin—atherosclerosis	0.000412	0.00213	CcSEcCtD
Clonidine—Urticaria—Ezetimibe—atherosclerosis	0.000412	0.00213	CcSEcCtD
Clonidine—Insomnia—Niacin—atherosclerosis	0.000411	0.00212	CcSEcCtD
Clonidine—Abdominal pain—Ezetimibe—atherosclerosis	0.00041	0.00212	CcSEcCtD
Clonidine—Body temperature increased—Ezetimibe—atherosclerosis	0.00041	0.00212	CcSEcCtD
Clonidine—Paraesthesia—Niacin—atherosclerosis	0.000408	0.00211	CcSEcCtD
Clonidine—Feeling abnormal—Simvastatin—atherosclerosis	0.000407	0.00211	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000407	0.00211	CcSEcCtD
Clonidine—Dyspnoea—Niacin—atherosclerosis	0.000405	0.00209	CcSEcCtD
Clonidine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000404	0.00209	CcSEcCtD
Clonidine—Insomnia—Pravastatin—atherosclerosis	0.000404	0.00209	CcSEcCtD
Clonidine—Somnolence—Niacin—atherosclerosis	0.000404	0.00209	CcSEcCtD
Clonidine—Paraesthesia—Pravastatin—atherosclerosis	0.000401	0.00208	CcSEcCtD
Clonidine—Dyspnoea—Pravastatin—atherosclerosis	0.000398	0.00206	CcSEcCtD
Clonidine—Decreased appetite—Niacin—atherosclerosis	0.000395	0.00204	CcSEcCtD
Clonidine—Rash—Rosuvastatin—atherosclerosis	0.000393	0.00203	CcSEcCtD
Clonidine—Dermatitis—Rosuvastatin—atherosclerosis	0.000393	0.00203	CcSEcCtD
Clonidine—Urticaria—Simvastatin—atherosclerosis	0.000393	0.00203	CcSEcCtD
Clonidine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000392	0.00203	CcSEcCtD
Clonidine—Abdominal pain—Simvastatin—atherosclerosis	0.000391	0.00202	CcSEcCtD
Clonidine—Body temperature increased—Simvastatin—atherosclerosis	0.000391	0.00202	CcSEcCtD
Clonidine—Headache—Rosuvastatin—atherosclerosis	0.000391	0.00202	CcSEcCtD
Clonidine—Hypersensitivity—Lovastatin—atherosclerosis	0.000389	0.00201	CcSEcCtD
Clonidine—Decreased appetite—Pravastatin—atherosclerosis	0.000389	0.00201	CcSEcCtD
Clonidine—Pain—Niacin—atherosclerosis	0.000388	0.00201	CcSEcCtD
Clonidine—Fatigue—Pravastatin—atherosclerosis	0.000385	0.00199	CcSEcCtD
Clonidine—Constipation—Pravastatin—atherosclerosis	0.000382	0.00198	CcSEcCtD
Clonidine—Pain—Pravastatin—atherosclerosis	0.000382	0.00198	CcSEcCtD
Clonidine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000382	0.00198	CcSEcCtD
Clonidine—Asthenia—Lovastatin—atherosclerosis	0.000379	0.00196	CcSEcCtD
Clonidine—Pruritus—Lovastatin—atherosclerosis	0.000374	0.00193	CcSEcCtD
Clonidine—Asthenia—Ezetimibe—atherosclerosis	0.000372	0.00192	CcSEcCtD
Clonidine—Gastrointestinal pain—Niacin—atherosclerosis	0.000371	0.00192	CcSEcCtD
Clonidine—Nausea—Rosuvastatin—atherosclerosis	0.00037	0.00192	CcSEcCtD
Clonidine—Feeling abnormal—Pravastatin—atherosclerosis	0.000368	0.00191	CcSEcCtD
Clonidine—Pruritus—Ezetimibe—atherosclerosis	0.000367	0.0019	CcSEcCtD
Clonidine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000365	0.00189	CcSEcCtD
Clonidine—Hypersensitivity—Simvastatin—atherosclerosis	0.000364	0.00188	CcSEcCtD
Clonidine—Diarrhoea—Lovastatin—atherosclerosis	0.000362	0.00187	CcSEcCtD
Clonidine—Urticaria—Niacin—atherosclerosis	0.000361	0.00187	CcSEcCtD
Clonidine—Abdominal pain—Niacin—atherosclerosis	0.000359	0.00186	CcSEcCtD
Clonidine—Body temperature increased—Niacin—atherosclerosis	0.000359	0.00186	CcSEcCtD
Clonidine—Urticaria—Pravastatin—atherosclerosis	0.000355	0.00184	CcSEcCtD
Clonidine—Asthenia—Simvastatin—atherosclerosis	0.000355	0.00183	CcSEcCtD
Clonidine—Diarrhoea—Ezetimibe—atherosclerosis	0.000355	0.00183	CcSEcCtD
Clonidine—Abdominal pain—Pravastatin—atherosclerosis	0.000353	0.00183	CcSEcCtD
Clonidine—Body temperature increased—Pravastatin—atherosclerosis	0.000353	0.00183	CcSEcCtD
Clonidine—Pruritus—Simvastatin—atherosclerosis	0.00035	0.00181	CcSEcCtD
Clonidine—Dizziness—Lovastatin—atherosclerosis	0.000349	0.00181	CcSEcCtD
Clonidine—Dizziness—Ezetimibe—atherosclerosis	0.000343	0.00177	CcSEcCtD
Clonidine—Diarrhoea—Simvastatin—atherosclerosis	0.000338	0.00175	CcSEcCtD
Clonidine—Vomiting—Lovastatin—atherosclerosis	0.000336	0.00174	CcSEcCtD
Clonidine—Hypersensitivity—Niacin—atherosclerosis	0.000334	0.00173	CcSEcCtD
Clonidine—Rash—Lovastatin—atherosclerosis	0.000333	0.00172	CcSEcCtD
Clonidine—Dermatitis—Lovastatin—atherosclerosis	0.000333	0.00172	CcSEcCtD
Clonidine—Headache—Lovastatin—atherosclerosis	0.000331	0.00171	CcSEcCtD
Clonidine—Vomiting—Ezetimibe—atherosclerosis	0.00033	0.00171	CcSEcCtD
Clonidine—Hypersensitivity—Pravastatin—atherosclerosis	0.000329	0.0017	CcSEcCtD
Clonidine—Dizziness—Simvastatin—atherosclerosis	0.000327	0.00169	CcSEcCtD
Clonidine—Rash—Ezetimibe—atherosclerosis	0.000327	0.00169	CcSEcCtD
Clonidine—Dermatitis—Ezetimibe—atherosclerosis	0.000327	0.00169	CcSEcCtD
Clonidine—Asthenia—Niacin—atherosclerosis	0.000326	0.00168	CcSEcCtD
Clonidine—Headache—Ezetimibe—atherosclerosis	0.000325	0.00168	CcSEcCtD
Clonidine—Pruritus—Niacin—atherosclerosis	0.000321	0.00166	CcSEcCtD
Clonidine—Asthenia—Pravastatin—atherosclerosis	0.000321	0.00166	CcSEcCtD
Clonidine—Pruritus—Pravastatin—atherosclerosis	0.000316	0.00164	CcSEcCtD
Clonidine—Vomiting—Simvastatin—atherosclerosis	0.000314	0.00163	CcSEcCtD
Clonidine—Nausea—Lovastatin—atherosclerosis	0.000314	0.00162	CcSEcCtD
Clonidine—Rash—Simvastatin—atherosclerosis	0.000312	0.00161	CcSEcCtD
Clonidine—Dermatitis—Simvastatin—atherosclerosis	0.000311	0.00161	CcSEcCtD
Clonidine—Diarrhoea—Niacin—atherosclerosis	0.000311	0.00161	CcSEcCtD
Clonidine—Headache—Simvastatin—atherosclerosis	0.00031	0.0016	CcSEcCtD
Clonidine—Nausea—Ezetimibe—atherosclerosis	0.000308	0.00159	CcSEcCtD
Clonidine—Diarrhoea—Pravastatin—atherosclerosis	0.000306	0.00158	CcSEcCtD
Clonidine—Dizziness—Niacin—atherosclerosis	0.0003	0.00155	CcSEcCtD
Clonidine—Diclofenac—PTGS2—atherosclerosis	0.0003	0.0476	CrCbGaD
Clonidine—Dizziness—Pravastatin—atherosclerosis	0.000296	0.00153	CcSEcCtD
Clonidine—Nausea—Simvastatin—atherosclerosis	0.000294	0.00152	CcSEcCtD
Clonidine—Vomiting—Niacin—atherosclerosis	0.000289	0.00149	CcSEcCtD
Clonidine—Rash—Niacin—atherosclerosis	0.000286	0.00148	CcSEcCtD
Clonidine—Dermatitis—Niacin—atherosclerosis	0.000286	0.00148	CcSEcCtD
Clonidine—Headache—Niacin—atherosclerosis	0.000284	0.00147	CcSEcCtD
Clonidine—Vomiting—Pravastatin—atherosclerosis	0.000284	0.00147	CcSEcCtD
Clonidine—Rash—Pravastatin—atherosclerosis	0.000282	0.00146	CcSEcCtD
Clonidine—Dermatitis—Pravastatin—atherosclerosis	0.000282	0.00146	CcSEcCtD
Clonidine—Headache—Pravastatin—atherosclerosis	0.00028	0.00145	CcSEcCtD
Clonidine—Nausea—Niacin—atherosclerosis	0.00027	0.00139	CcSEcCtD
Clonidine—Diclofenac—ALB—atherosclerosis	0.000267	0.0424	CrCbGaD
Clonidine—Nausea—Pravastatin—atherosclerosis	0.000265	0.00137	CcSEcCtD
Clonidine—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	8.04e-06	6.08e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	8.01e-06	6.06e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ALB—atherosclerosis	7.99e-06	6.04e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—NOS3—atherosclerosis	7.98e-06	6.03e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	7.95e-06	6.01e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—APOE—atherosclerosis	7.93e-06	6e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOS3—atherosclerosis	7.91e-06	5.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CG—atherosclerosis	7.91e-06	5.98e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARA—atherosclerosis	7.89e-06	5.97e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	7.88e-06	5.96e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CAV1—atherosclerosis	7.85e-06	5.94e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—APOA1—atherosclerosis	7.84e-06	5.93e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CG—atherosclerosis	7.81e-06	5.9e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—HMOX1—atherosclerosis	7.8e-06	5.9e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	7.78e-06	5.89e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	7.78e-06	5.89e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	7.71e-06	5.83e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	7.7e-06	5.82e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	7.7e-06	5.82e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—NOS3—atherosclerosis	7.65e-06	5.78e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AGT—atherosclerosis	7.64e-06	5.78e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—INS—atherosclerosis	7.61e-06	5.75e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—MAPK3—atherosclerosis	7.58e-06	5.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	7.56e-06	5.72e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PPARG—atherosclerosis	7.53e-06	5.7e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—APOE—atherosclerosis	7.49e-06	5.66e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—INS—atherosclerosis	7.49e-06	5.66e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	7.49e-06	5.66e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	7.48e-06	5.66e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOB—atherosclerosis	7.47e-06	5.65e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	7.43e-06	5.62e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CAV1—atherosclerosis	7.42e-06	5.61e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—APOA1—atherosclerosis	7.4e-06	5.6e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—INS—atherosclerosis	7.39e-06	5.59e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AGT—atherosclerosis	7.38e-06	5.58e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCL2—atherosclerosis	7.37e-06	5.57e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	7.36e-06	5.57e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—HMOX1—atherosclerosis	7.35e-06	5.56e-05	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—atherosclerosis	7.35e-06	5.56e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.35e-06	5.56e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—F2—atherosclerosis	7.34e-06	5.55e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PTGS2—atherosclerosis	7.3e-06	5.52e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GSTM1—atherosclerosis	7.27e-06	5.5e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCA1—atherosclerosis	7.26e-06	5.49e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NAMPT—atherosclerosis	7.25e-06	5.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IGF1—atherosclerosis	7.24e-06	5.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	7.23e-06	5.47e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	7.23e-06	5.47e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LIPC—atherosclerosis	7.2e-06	5.45e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	7.17e-06	5.42e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOC3—atherosclerosis	7.16e-06	5.42e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.15e-06	5.41e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	7.15e-06	5.41e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	7.14e-06	5.4e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—LPL—atherosclerosis	7.14e-06	5.4e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LDLR—atherosclerosis	7.12e-06	5.38e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOB—atherosclerosis	7.04e-06	5.33e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	7.03e-06	5.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CXCL8—atherosclerosis	7.02e-06	5.31e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTGS2—atherosclerosis	6.99e-06	5.29e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	6.99e-06	5.28e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GPX1—atherosclerosis	6.96e-06	5.27e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CETP—atherosclerosis	6.95e-06	5.26e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	6.91e-06	5.22e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PPARG—atherosclerosis	6.9e-06	5.22e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SERPINE1—atherosclerosis	6.88e-06	5.2e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.85e-06	5.18e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—F2—atherosclerosis	6.82e-06	5.16e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CD36—atherosclerosis	6.78e-06	5.13e-05	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—atherosclerosis	6.78e-06	5.13e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ALB—atherosclerosis	6.78e-06	5.12e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—INS—atherosclerosis	6.77e-06	5.12e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CG—atherosclerosis	6.76e-06	5.11e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	6.73e-06	5.09e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—LPL—atherosclerosis	6.72e-06	5.09e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—IL6—atherosclerosis	6.67e-06	5.05e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	6.67e-06	5.05e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.66e-06	5.03e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—INS—atherosclerosis	6.65e-06	5.03e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOS3—atherosclerosis	6.57e-06	4.97e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GPX1—atherosclerosis	6.56e-06	4.96e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	6.54e-06	4.95e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	6.53e-06	4.94e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PPARG—atherosclerosis	6.52e-06	4.93e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—NOS3—atherosclerosis	6.48e-06	4.9e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	6.43e-06	4.86e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—atherosclerosis	6.43e-06	4.86e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—INS—atherosclerosis	6.4e-06	4.84e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CD36—atherosclerosis	6.39e-06	4.83e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MMP9—atherosclerosis	6.35e-06	4.8e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	6.34e-06	4.79e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARA—atherosclerosis	6.3e-06	4.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMGCR—atherosclerosis	6.29e-06	4.75e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NFKB1—atherosclerosis	6.28e-06	4.75e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	6.25e-06	4.73e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HMOX1—atherosclerosis	6.23e-06	4.71e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ALB—atherosclerosis	6.21e-06	4.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—INS—atherosclerosis	6.18e-06	4.67e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK8—atherosclerosis	6.17e-06	4.67e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—atherosclerosis	6.16e-06	4.66e-05	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	6.12e-06	4.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	6.11e-06	4.62e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AGT—atherosclerosis	6.11e-06	4.62e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	6.08e-06	4.6e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—atherosclerosis	6.05e-06	4.58e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	6.02e-06	4.56e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—atherosclerosis	6.01e-06	4.55e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOE—atherosclerosis	5.98e-06	4.52e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	5.98e-06	4.52e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOB—atherosclerosis	5.97e-06	4.51e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARA—atherosclerosis	5.94e-06	4.49e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—NOS3—atherosclerosis	5.94e-06	4.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—atherosclerosis	5.93e-06	4.48e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CAV1—atherosclerosis	5.93e-06	4.48e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	5.92e-06	4.48e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOA1—atherosclerosis	5.91e-06	4.47e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—atherosclerosis	5.87e-06	4.44e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	5.83e-06	4.41e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—atherosclerosis	5.82e-06	4.4e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—atherosclerosis	5.8e-06	4.39e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AGT—atherosclerosis	5.75e-06	4.35e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	5.73e-06	4.33e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	5.72e-06	4.32e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—atherosclerosis	5.7e-06	4.31e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—LPL—atherosclerosis	5.7e-06	4.31e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	5.68e-06	4.29e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	5.67e-06	4.29e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—atherosclerosis	5.64e-06	4.27e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOE—atherosclerosis	5.64e-06	4.26e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	5.63e-06	4.26e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—atherosclerosis	5.63e-06	4.26e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NOS3—atherosclerosis	5.61e-06	4.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.6e-06	4.24e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CAV1—atherosclerosis	5.59e-06	4.22e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	5.57e-06	4.21e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOA1—atherosclerosis	5.57e-06	4.21e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GPX1—atherosclerosis	5.56e-06	4.2e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	5.56e-06	4.2e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—atherosclerosis	5.54e-06	4.19e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.43e-06	4.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	5.42e-06	4.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CD36—atherosclerosis	5.41e-06	4.09e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.4e-06	4.08e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—atherosclerosis	5.39e-06	4.08e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	5.35e-06	4.05e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	5.3e-06	4.01e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—atherosclerosis	5.27e-06	3.98e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—atherosclerosis	5.23e-06	3.96e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NFKB1—atherosclerosis	5.21e-06	3.94e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PPARG—atherosclerosis	5.21e-06	3.94e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	5.21e-06	3.94e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	5.19e-06	3.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	5.17e-06	3.91e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	5.15e-06	3.89e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—atherosclerosis	5.13e-06	3.88e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—atherosclerosis	5.13e-06	3.88e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK8—atherosclerosis	5.12e-06	3.87e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—INS—atherosclerosis	5.11e-06	3.86e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—atherosclerosis	5.11e-06	3.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	5.09e-06	3.85e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	5.09e-06	3.85e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARA—atherosclerosis	5.03e-06	3.81e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	5e-06	3.78e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	4.92e-06	3.72e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PPARG—atherosclerosis	4.91e-06	3.71e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AGT—atherosclerosis	4.87e-06	3.69e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	4.87e-06	3.68e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—INS—atherosclerosis	4.82e-06	3.64e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.81e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	4.81e-06	3.64e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	4.81e-06	3.63e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOE—atherosclerosis	4.78e-06	3.61e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	4.76e-06	3.6e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CAV1—atherosclerosis	4.73e-06	3.58e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—atherosclerosis	4.73e-06	3.58e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	4.72e-06	3.57e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOA1—atherosclerosis	4.72e-06	3.57e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—atherosclerosis	4.68e-06	3.54e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—atherosclerosis	4.68e-06	3.54e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	4.68e-06	3.54e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	4.64e-06	3.51e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	4.63e-06	3.5e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOB—atherosclerosis	4.6e-06	3.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	4.57e-06	3.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	4.55e-06	3.44e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	4.55e-06	3.44e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	4.54e-06	3.43e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NOS3—atherosclerosis	4.48e-06	3.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.48e-06	3.39e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—atherosclerosis	4.47e-06	3.38e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—atherosclerosis	4.41e-06	3.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	4.41e-06	3.34e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—LPL—atherosclerosis	4.4e-06	3.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	4.35e-06	3.29e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—atherosclerosis	4.34e-06	3.28e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—atherosclerosis	4.31e-06	3.26e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	4.3e-06	3.25e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GPX1—atherosclerosis	4.29e-06	3.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	4.23e-06	3.2e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NOS3—atherosclerosis	4.22e-06	3.19e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	4.22e-06	3.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	4.2e-06	3.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD36—atherosclerosis	4.18e-06	3.16e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	4.16e-06	3.15e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PPARG—atherosclerosis	4.16e-06	3.15e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—atherosclerosis	4.1e-06	3.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—INS—atherosclerosis	4.08e-06	3.09e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	3.97e-06	3.01e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.96e-06	2.99e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—atherosclerosis	3.94e-06	2.98e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	3.9e-06	2.95e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARA—atherosclerosis	3.88e-06	2.94e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	3.87e-06	2.92e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.86e-06	2.92e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	3.86e-06	2.92e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AGT—atherosclerosis	3.76e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—atherosclerosis	3.74e-06	2.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	3.69e-06	2.79e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOE—atherosclerosis	3.69e-06	2.79e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—atherosclerosis	3.67e-06	2.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAV1—atherosclerosis	3.65e-06	2.76e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOA1—atherosclerosis	3.64e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—atherosclerosis	3.64e-06	2.75e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	3.58e-06	2.71e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NOS3—atherosclerosis	3.58e-06	2.71e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—atherosclerosis	3.56e-06	2.69e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—atherosclerosis	3.51e-06	2.66e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.33e-06	2.52e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—atherosclerosis	3.32e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	3.28e-06	2.48e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.27e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—atherosclerosis	3.27e-06	2.47e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PPARG—atherosclerosis	3.21e-06	2.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—INS—atherosclerosis	3.15e-06	2.38e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	3.07e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—atherosclerosis	3.02e-06	2.28e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.98e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.91e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—atherosclerosis	2.89e-06	2.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NOS3—atherosclerosis	2.76e-06	2.09e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—atherosclerosis	2.73e-06	2.06e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.7e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.68e-06	2.03e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—atherosclerosis	2.58e-06	1.95e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.53e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	2.49e-06	1.88e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—atherosclerosis	2.06e-06	1.56e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.94e-06	1.47e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—atherosclerosis	1.64e-06	1.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—atherosclerosis	1.27e-06	9.6e-06	CbGpPWpGaD
